(Q45951593)

18 December 2017

title

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. (English)

1 reference

18 December 2017

0 references

1 reference

4

1 reference

18 December 2017

Valerio Nobili

Valerio Nobili

6

0 references

Ariel E Feldstein

1

Ariel E Feldstein

1 reference

18 December 2017

Rita De Vito

3

Rita De Vito

1 reference

18 December 2017

Naim Alkhouri

2

Naim Alkhouri

1 reference

18 December 2017

author name string

Rocio Lopez

5

1 reference

18 December 2017

language of work or name

English

0 references

publication date

11 June 2013

1 reference

18 December 2017

The American Journal of Gastroenterology

published in

1 reference

18 December 2017

volume

108

1 reference

18 December 2017

issue

9

1 reference

18 December 2017

page(s)

1526-1531

1 reference

18 December 2017

Nonalcoholic fatty liver disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Features, diagnosis, and treatment of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Establishing a standard definition for child overweight and obesity worldwide: international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Lowering the criterion for impaired fasting glucose is in order

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Endpoints and clinical trial design for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.168

21 January 2018

Identifiers

DOI

10.1038/AJG.2013.168

1 reference

18 December 2017

PubMed ID

23752877

1 reference

18 December 2017